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Health Reform: A Work In Progress
By David B. Nash, MD, MBA
Editor-in-Chief

It has been 5 years since we, in
partnership with Eli Lilly and Company,
introduced Prescriptions for Excellence in
Health Care (PEHC), a unique newsletter
series devoted to the evolving national
quality improvement agenda. Since its
launch in 2007, the newsletter has been
provided as a supplement to our Health
Policy Newsletter (HPN). This issue
marks 2 important beginnings – a new
4-part series on the present and future
impact of health care reform and, as HPN
goes exclusively electronic, the debut of
PEHC as a stand-alone publication.
Like many of our readers, I have
followed the implementation of the
Patient Protection and Affordable
Care Act (ACA) with keen interest,
some trepidation, and a certain amount
of optimism. As we go to press, it is
almost 2 years since the passage of this
historic, game-changing legislation that
promises to influence how health care is
delivered and reimbursed in the United
States for decades to come.

This newsletter was jointly developed and
subject to editorial review by Jefferson
School of Population Health and Lilly
USA, LLC, and is supported through
funding by Lilly USA, LLC. The content
and viewpoints expressed are those of the
individual authors, and are not necessarily
those of Lilly USA, LLC or the Jefferson
School of Population Health.

Debates continue to rage about the
ACA’s design, its intended effects,
and whose way is best. But, lawsuits
and court challenges by some states

notwithstanding, the ACA and the
overwhelming majority of its provisions
are here to stay.
Although the popular media tends
to focus on the few hot-button issues
(eg, charges of amendment violations,
“death panels”), an astounding array of
provisions have already gone into effect
across the entire industry. In the first
year alone (2010), insurers faced a variety
of new requirements, such as: increased
mandatory reporting of administrative
data, continued coverage of adult
children under their parents’ policies
(until the 26th birthday), strict limits on
reasons for discontinuing coverage, and
free preventive screening services for
adults. Nonprofit insurers were required
to maintain a medical loss ratio of 85%
or higher in order to take advantage of
Internal Revenue Service tax benefits.
Prescriptions for Excellence in Health
Care is brought to Health Policy
Newsletter readers by Jefferson School
of Population Health in partnership
with Lilly USA, LLC to provide
essential information from the quality
improvement and patient safety arenas.

(continued on page 2)
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Other provisions that went into
effect in 2010 include new tax credits
available to small businesses (those
with 25 or fewer employees) to help
with employee premium costs and the
expansion of Medicare to small, rural
hospitals and facilities.
In January 2011, Medicare
beneficiaries began to receive free
preventive care as well as a 50%
discount on the cost of covered
brand-name prescription drugs for the
Medicare Part D coverage gap (donut
hole). Grants became available to
states to develop programs aimed
at delaying the onset and reducing
the prevalence of chronic conditions
among Medicaid beneficiaries.
Hospitals, too, have begun to feel
the impact of ACA as the federal
government ceased making payments
to states for Medicaid services
related to certain hospital-acquired
infections – a precursor to a reduction
in Medicare payments for preventable
hospital admissions scheduled to take
effect in 2012.
On the policy front, the Centers for
Medicare and Medicaid Services

has met its deadline for developing
the CMS Center for Medicare and
Medicaid Innovation, the body that
will oversee testing of innovative
payment and delivery models.

Care,” describes one residency
program’s approach to improving how
preventive medicine specialists are
prepared to meet the expectations of
health reform.

In the summer of 2011, we convened
a symposium to get a snapshot of how
various provisions of the ACA have
begun to affect health care quality and
population health. With presentations
from a cross section of stakeholder
groups, we had an opportunity to learn
how things are going on the front
lines, from primary care to long-term
care to policy making. Three of these
presentations form the basis of the
articles in this issue.

The third article is one that certainly
piqued my interest. Exploring another
key component of health reform,
“Leveraging Electronic Health Records
in Comparative Effectiveness Research”
translates a complex sounding concept
into terms that are easily understood
and thought provoking.

The first article, “The Role of Primary
Care in Health Care Reform,” examines
3 current ACA-related initiatives
that have the potential to reinforce
primary care as the foundation for
assuring the success of health care
reform.
Prevention plays either a starring
or supporting role in many ACA
provisions. The second article, “A
New Model for Integrating Clinical
Preventive Medicine into Patient

I hope that this issue and others in
this series will shed new light on some
of the changes that are occurring
as health care reform unfolds. As
always, I welcome questions and
comments from readers. I can be
reached at: david.nash@jefferson.edu.
David B. Nash, MD, MBA, is the Dean
and the Dr. Raymond C. and Doris N.
Grandon Professor of Health Policy at
the Jefferson School of Population Health
(JSPH) of Thomas Jefferson University
in Philadelphia, PA.

A Message from Lilly
The Continued Evolution of Health Care Reform in the United States
By Barton R. Peterson, BS, JD
Health care reform in the United
States was inevitable. In the absence
of any changes to federal law, 25%
of total US Gross Domestic Product
would have been spent on health care
by 2025. A system that provided
financial incentives for services
without regard for patient outcomes
was bound to hit the wall. We were

spending nearly twice what the rest
of the developed world spent on
health care, yet measures of quality
suggested that US health care was
not twice as good. It was time for a
fundamental reevaluation.
There was much speculation about
why the biopharmaceutical industry

jumped headlong into the health
care reform debate in 2009. The
industry supported what became
the Affordable Care Act (ACA)
despite the enormous additional
expenditures it imposed on
biopharmaceutical companies. Why?
The simplest answer is that the
system’s flaws were catching up

This newsletter was jointly developed and subject to editorial review by Jefferson School of Population Health and Lilly USA, LLC, and is supported through funding by Lilly USA, LLC.
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with it and producing results that
were not in Americans’ best interests
– most importantly, the patients who
were its intended beneficiaries.
This issue of Prescriptions for
Excellence in Health Care comes
at a very uncertain time. The US
Supreme Court will decide the fate
of at least the individual mandate in
the ACA, if not the fate of the entire
law. Regardless of how the high
court rules, the 2012 elections could
result in a Republican president
and a Republican-controlled
Congress – 2 entities that have
pledged to repeal the ACA. If
President Obama is reelected, he
may face a Republican Congress
that imposes limits on funding the
implementation of certain ACA
provisions. And then there are the
States, which have responsibility for
insurance exchanges, the expansion
of Medicaid, and other critical
components of the new law.
The foregoing challenges aside, it
is a very good time to discuss the
issues presented on the following
pages. If the ACA survives, it
must evolve. Even its staunchest
supporters admit that. If it is
repealed, it must be replaced with
something else. Otherwise, we’re
in the same place we were 2 years
ago – with millions of uninsured
people, unsustainable growth in
expenditures, and little to show in
the way of improved outcomes and
higher quality.

In the biopharmaceutical industry,
there are many opinions as to what
such an improved system might
look like, and I have my own. The
movement toward compensating
those in the health care system
for improved individual health
outcomes is inexorable, but it will
be a terribly complicated thing to
do. The ACA puts a number of
“toes in the water” on the subject
of paying for results, Accountable
Care Organizations being the
most prominent. When so many
different individuals and institutions
are involved in the care of a single
person, how do we distinguish who
performed well from who performed
poorly and, importantly, how do
we compensate them accordingly?
What about the role of the health
care consumer in his or her own
health? What about prevention?

3

Outcomes for Individual Patients.”
These are not empty words. They
drive the actions of our employees
across the world every day.
US health care reform is closer to
the beginning than the end. At
least our county is now purposefully
focused on real issues and real
solutions. It is imperative that this
focus lead to a sustainable health
care system that produces better
outcomes for all Americans.
Barton R. Peterson, BS, JD, is Sr.
Vice President, Corporate Affairs/
Communications at Eli Lilly and
Company.

I believe that the age of health
care “silos” will come to an end. A
system that pays only for products
and services facilitates siloed
providers, and vice versa. The
biopharmaceutical industry provides
essential innovation for the benefit
of patients and value for the health
care system but is compensated
solely on the number of pills and
vials it sells. I hope the business
model for biopharmaceutical
companies evolves to the point
where they are seen as an integral
part of producing better individual
patient outcomes. At Lilly, our
corporate vision is “Improved

This newsletter was jointly developed and subject to editorial review by Jefferson School of Population Health and Lilly USA, LLC, and is supported through funding by Lilly USA, LLC.
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The Role of Primary Care in Health Care Reform
By Kenneth Goldblum, MD
Few discussions on health care reform
fail to mention the importance of
primary care and, indeed, primary care
plays such a critical role in health care
delivery that any successful health care
reform effort will necessarily depend
on a strong primary care foundation.
At the present time, that foundation is
not solid enough to fulfill its role. It
will need significant reinforcement if
reform is to succeed.1
For a patient experiencing a new
problem, primary care is generally
the first contact with the health care
system. Comprehensive in nature and
centered on the whole person rather
than a specific disease process or organ
system, primary care coordinates care
given by different providers in different
settings. It is continuous over time
and, as such, is forward looking and
prevention based.
Although health care reform
is multifaceted, with different
orientations depending on the context,
a majority of its goals target lowered
costs, improved quality and safety,
better access to care, and more patientcenteredness. By its very nature,
primary care supports these goals;
for example, studies of geographical
variation in costs in this country have
shown that areas with more primary
care have lower costs. On a macro
scale, this is supported by data showing
that countries with a higher percentage
of primary care doctors also have lower
costs. Outpatient quality improvement
efforts have focused on primary care
initiatives with specialist programs
lagging behind. Moreover, newer care
delivery models such as the Patient-

Centered Medical Home (PCMH) are
designed in part to improve both access
and patient-centeredness.
Despite the concordance between the
nature of primary care and the goals of
reform, primary care is ill equipped to
fulfill its potential foundational role.
Consider the following:

• At a mere 5% of total health

expenditures, primary care is
woefully underfunded. It is
trapped in a fee-for-service
payment methodology that
reimburses visits and does not
support the goals of reform.

• Primary care is fragmented, with

evidence revealing that in 1 year
the average Medicare patient
sees 2 primary care doctors and 5
specialists working in 4 different
locations.2

• Primary care is increasingly

isolated as fewer and fewer primary
care physicians practice in the
hospital setting.

• Primary care is time challenged,

with one study documenting
that it would take 7.4 hours per
day to provide all recommended
preventive care and another
revealing that it would take
10.6 hours per day to provide all
recommended chronic care.3

Despite recent efforts, including those
contained in the Affordable Care
Act, primary care doctors remain in
short supply. Market forces likely will
exacerbate this problem.

Three initiatives currently under way
or close to starting have the potential
to help improve the situation for
primary care. The first of these is
the PCMH, a care delivery model
innovation that seeks to improve the
core primary care functions of access,
comprehensiveness, coordination, and
quality improvement. Although it does
deliver results in these areas, the data
are not as robust with regard to cost
reduction. The extent to which PCMH
is truly able to drive change depends
primarily on payers supporting the
concept. In the absence of strong data
on cost reduction, such payer support
remains in question.
The second initiative currently
affecting primary care is payment for
meaningful use (MU) of electronic
medical records (EMR). Legislated
through the American Recovery
and Reinvestment Act in 2009, final
criteria for the first stage of MU were
recently established, and the first wave
of practices is now in the certifying
process. Anecdotal evidence suggests
that the criteria will represent a
difficult stretch for many physician
practices and therefore may not be
a significant driver of change. On
the positive side, the 2011 standards
for National Committee for Quality
Assurance PCMH certification include
many of the same elements that are
necessary for MU certification, so a
practice that certifies as a meaningful
user of EMR will be well on its way to
PCMH certification as well.
The last initiative, one that begins
soon, is the Medicare Shared Savings
Program. Preliminary rules were
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published in March of 2011, and
the final rules are still pending at
the time of this writing. While the
term Accountable Care Organization
(ACO) is used in other contexts,
here it refers to a business structure
of providers of traditional Medicare
services who will contract with the
Centers for Medicare and Medicaid
Services to engage in a shared savings
program. The sharing of savings is
first predicated on the organization’s
achievement of acceptable performance
levels on specific quality measures.
The preliminary rules describe 65
such measures, many of which are
outpatient, primary care-based
measures. Five of the measures are MU
measures, and there is a requirement
that 50% of the ACO’s primary care
doctors be certified as meaningful users
of EMR by the ACO’s second year.
Because ACOs will be held liable
for losses incurred under the Shared
Savings Program, they also must be
risk-bearing entities with sufficient
capital – a resource not typically
associated with primary care
physicians. Given that participation in
the ACO is entirely at the discretion of
the primary care doctor, this initiative
does have the potential to better fund
primary care if the practitioners are
able to leverage this with a strategically
aligned capital partner.4
Although these 3 initiatives have
different origins and different goals,
they tie together and support each
other. As noted, practices that can
certify as meaningful users of EMR
are well on the way to PCMH

certification, and MU certification is
critical for ACO participation. PCMH
certification, in turn, goes a long way
toward meeting the proposed ACO
quality measures. Only the ACO is
a true payment methodology reform
but, to the extent that the PCMH is
embedded in the ACO and driving
its quality, the ACO may provide the
PCMH with financial support. Many
themes of reform – from cost reduction
to quality improvement to better
patient-centeredness – run through all
3 of these initiatives.
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Although each of these initiatives has
the potential to improve the plight of
primary care, a true bolstering of the
foundational role of primary care (and
thereby a true support of the delivery
system as a whole) will depend on new
payment mechanisms that support the
goals of reform. To accomplish this
will require fundamental reform that
uncouples reimbursement from the
individual visit and creates incentives
for team building.5
A reimbursement system that pays for
visits will continue to produce visits
without necessarily improving access,
comprehensiveness, safety, or quality
of care. Conversely, a reimbursement
system that rewards the goals of
reform has the potential to address the
challenges of primary care and, hence,
improve the delivery system as a whole.
Kenneth Goldblum, MD, is Chief
Medical Officer of Renaissance Medical
Management Company. He can be
reached at kgoldblum@rmmcdocs.com.
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A New Model for Integrating Clinical Preventive Medicine into Patient Care
By Kevin L. Bowman, MD, MBA, MPH
The General Preventive Medicine
Residency (GPMR) Program of the
Johns Hopkins Bloomberg School
of Public Health is one of the oldest
and largest preventive medicine (PM)
residency programs in the country.
The mission of the residency program
is as follows1:
To prepare physicians in the theoretical,
practical, and clinical knowledge and
skills essential to leadership roles in the
design, management, and evaluation of
population-based approaches to health.
Basic to this mission are 5 key goals:
• To instill in residents the ability to
synthesize clinical and populationbased approaches to disease
prevention and health promotion
• To view health issues on a broad
continuum that ranges from local
to international in perspective
• To discover and apply knowledge
toward the protection of the
public’s health
• To provide residents with the
management and epidemiologic skills
needed to address the overall health
needs of underserved populations
• To provide residents with
the clinical skills needed to
treat specific diseases that
disproportionately affect
underserved populations.1
Each year, approximately 10 resident
physicians enter the GPMR Program

after completing at least 1 year of
clinical training in an Accreditation
Council for Graduate Medical
Education (ACGME)-accredited
program. One student is accepted
directly from medical school through
the match process and completes the
required clinical training at Basset
Healthcare Hospital in Cooperstown,
NY. Approximately half of the other
9 residents who enter the program
each year have completed a partial
clinical residency in another specialty
(eg, internal medicine, radiology,
neurosurgery) and have been in
practice for some time prior to entering
the program. The remaining residents
have completed full clinical residencies
(eg, pediatrics, family medicine,
internal medicine).
Like most PM residencies, the GPMR
Program is 2 years of specialty-specific
training that includes graduate level
course work and hands-on rotation
experiences. Although some PM
residencies spread the graduate
course work and rotation experiences
throughout the 2-year period, the
GPMR Program has separated the 2
disciplines into an academic (graduate
course work) year and a practicum
(rotation experience) year.
During the academic year, residents
have been full-time graduate students
in the Master of Public Health
(MPH) program at the Johns Hopkins
Bloomberg School of Public Health.
The school offers hundreds of
classes in a wide variety of areas, and
residents are encouraged to design a
personalized curriculum that meets

their interests and career goals. The
MPH course work has constituted
about 60% to 70% of their time. The
remaining time has been dedicated
to typical residency activities such
as journal clubs, grand rounds, and
numerous educational seminars/classes
on various topics (eg, problem-solving
skills in public health, health advocacy,
public health preparedness, quality
assessment/quality improvement,
budgeting and financial management,
conflict management and negotiation,
strategic leadership principles).
Residents have spent all 12 months
of the practicum year doing elective
rotations at a variety of sites to fulfill the
core competencies of the residency (ie,
biostatistics/epidemiology, health care
management and administration, clinical
preventive medicine, occupational/
environmental health). The rotation
sites have ranged from industry to
academia to government (local, state,
federal, and international) and include
hospitals, managed care organizations,
health departments, nongovernmental
organizations, community-based
organizations, pharmaceutical
companies, and consulting firms.
The following are examples of recent
resident rotation sites:
World Health Organization
Pan American Health Organization
Centers for Medicare and
Medicaid Services
Food and Drug Administration
Office of the National Coordinator on
Health Information Technology
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Office of the Surgeon General
Agency for Healthcare Research
and Quality
Maryland State Health Department

Figure 1. ACGME Program Requirements for Graduate Medical Education in
Preventive Medicine
ACGME Program Requirements for Graduate Medical Education in
Preventive Medicine

Maryland General Assembly

Effective July 1, 2011

Baltimore City Health Department

IV.A.6. Curriculum Organization and Resident Experiences

Capitol Hill

	IV.A.6.a.(2) Residents must have educational experiences within a patient
care environment that address direct clinical issues relevant to their area of
concentration.

GlaxoSmithKline
Booz Allen
Discovery Channel
The Dr. Oz Show
Until recently, the GPMR Program
had no formal requirements for direct
patient care in the hospital or in
any outpatient setting. This policy
changed as of July 1, 2011, when
new ACGME requirements for PM
went into effect. PM residents now
are required to have a minimum of 2
months of direct patient care during
each year of their residency (Figure 1).2
We sought to implement this patient
care experience in an innovative way,
keeping in mind 3 critical goals:
(1) Provide value to the GPMR
residents, the Johns Hopkins
health care system, and our
patients
(2) Focus on prevention/chronic
care rather than acute care (eg,
counseling individuals on health
promoting behaviors such as diet,
exercise, and tobacco use)
(3) Leverage our training in
both clinical medicine and
population health.
To meet these requirements while
accomplishing our goals, we created a
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		IV.A.6.a.(2).(a) Each resident must have progressive responsibility
for direct patient care.
IV.A.6.a.(2).(b) Each resident must have progressive responsibility for
the management of health and provision of health care for a defined
population, as specified for their area of preventive medicine.

		

	IV.A.6.d.(2) Residents must have a minimum of two months of direct patient
care experience during each year of the program.
Source: Preventive Medicine Residency Review Committee. Preventive Medicine Program Requirements. http://www.acgme.org/
acWebsite/downloads/RRC_progReq/380_preventive_medicine_PRs_07012011.pdf . Accessed September 18, 2011.

new curriculum (clinical program) that
will expose residents to the different
ways preventive care can be delivered
and integrated throughout an entire
health care system.
Beginning in September 2011, GPMR
residents will spend one half day per
week for 2 years in a Johns Hopkins
Community Physicians ( JHCP) clinic,
the primary care outpatient clinics at
Johns Hopkins. Residents also will
work with Johns Hopkins HealthCare,
the health plan of Johns Hopkins that
administers health care services across
several different product lines. Through
didactic sessions, online modules, and
working directly with physicians, health
coaches/educators, and care managers,
residents will learn how to assess disease
risk, practice evidence-based behavioral
counseling and risk factor reduction,
apply shared decision-making strategies
to generate self-management tools for
patients, set up collaborative referrals

to health care professionals, and utilize
team-based management skills for
lifestyle-related conditions.
Residents also will learn about broader
concepts of health care delivery and
population management such as PatientCentered Medical Homes (PCMHs),
Accountable Care Organizations,
meaningful use of electronic health
records, disease registries, and
performance measurement/outcomes
evaluation (eg, utilizing health risk
assessments and administrative, pharmacy,
and laboratory claims data). Residents
will spend a portion of their time seeing
patients and providing preventive care,
and a portion of their time working
on projects to improve safety, quality,
population management, and/or
operations in a JHCP clinic, multiple
clinics, or across the entire Hopkins
health care system. Some residents
will work in a National Committee for
Quality Assurance-recognized PCMH.
(continued on page 8)
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Indeed, the landscape of medicine is
changing and, at Johns Hopkins, we
want to be ahead of the curve. We
used the new ACGME requirements
as an opportunity to create a new
model that better integrates preventive
medicine into patient care. We wanted
this new model to provide value for the
residents, value for the Johns Hopkins
health care system, and above all, value
for the many patients through our
planned interactions. We believe this
new model does that because of its

focus on promoting healthy behaviors
through preventive care at multiple
levels of the health care system.
We look forward to sharing our
experiences in the future and welcome
questions and feedback from readers.
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Leveraging Electronic Health Records in Comparative Effectiveness Research
By Andrew Masica, MD, MSCI and Ashley Collinsworth, MPH
Comparative Effectiveness Research
(CER) has been identified as a key
component of US health care reform.
The Institute of Medicine defines CER
as “the generation and synthesis of
evidence that compares the benefits and
harms of alternative methods to prevent,
diagnose, treat, and monitor a clinical
condition or to improve delivery of care”
for the purpose of allowing “consumers,
clinicians, purchasers, and policy
makers to make informed decisions that
will improve health care at both the
individual and population levels.”1
CER ultimately seeks to provide
pragmatic knowledge that can be
applied toward delivering “the right
treatment to the right patient at the
right time.”2 Achieving this goal in a
complex health care environment will
require robust, accessible data sources
capable of providing detailed patientlevel information in a time- and costefficient fashion. Electronic health
records (EHRs) are well suited to fill
that need, but current technical aspects
and methodologies of using these

systems as research tools are at an early
stage of development.
The Federal Coordinating Council for
CER (established by the American
Recovery and Reinvestment Act of
2009, which also included a $1.1
billion appropriation for CER)
advocated a strategic framework2 that
reflects the importance of EHRs in the
CER enterprise. As shown in Table 1,

the core components of CER outlined
by the Council are strongly influenced
and enhanced by EHRs, particularly
those with functionalities that allow
interoperability and data exchange.
EHRs also help address the
disconnection between the vast amount
of health care data that are available
and our ability to access and organize
those data in a way that is meaningful

Table 1. Relationships between the Comparative Effectiveness Research (CER) Strategic
Framework and Electronic Health Records (EHRs)
CER Activity/Investment

EHR Support of Activity/Investment

Research Content

• End product of investigators applying EHRs effectively
• Accelerated research production time frame

Human and Scientific Capital

•
 Human resources to extract and configure electronic data
• EHR appropriate study design and analysis methodologies
• Hardware/software that facilitates research

Data Infrastructure

• Longitudinal patient registries
• Development of distributive data networks

Dissemination and Translation

• Clinical decision support embedded into EHR workflows
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for CER. More than ever before,
health care is “information rich,” as
interactions between clinicians and
patients produce a myriad of data
points including diagnoses, laboratory
results, images, interventions, and
responses to treatments.3
Historically, it has been difficult to
use data collected as a part of routine
patient care to perform research
efficiently because the material of
interest often was buried in paper
charts or archived records and
scattered across the siloed care sites.
This incongruity has hampered the
development of evidence to determine
which intervention(s) works best for
individual patients. EHRs offer a
potential mechanism to identify and
compile relevant clinical information
for the full spectrum of patients across
the continuum of care, to structure
that data, and to enable appropriate
comparisons of treatments from a
single source.
Until the recent movement toward
widespread EHR implementation, the
type of original research (excluding
systematic literature reviews) that
would satisfy criteria as a CER
study would necessitate undertaking
a clinical trial, conducting costly
and time-consuming manual
audits of paper charts, or relying on
administrative data, which may be
inaccurate and lacking in granular
clinical information.
Although randomized controlled trials
(RCTs) have long been considered the
gold standard for comparing efficacy,
these types of studies are performed
in highly controlled environments
in which patients are selected based
on strict inclusion criteria and in
which treatment adherence is closely

monitored. Research regulations, study
logistics, and negative perceptions of
research in certain populations often
make it difficult or impossible to
include certain subgroups (eg, children,
pregnant women, the elderly, minorities,
people with multiple chronic conditions,
those with rare diseases) in clinical
trials.4 Thus, the results of RCTs often
have limited generalizability to an
affected patient population, whereas a
central tenet of CER is to determine
what works in “real world” settings.5
Lastly, RCTs are expensive and cannot
be modified easily to include additional
patient data over time or account for
emerging care improvements.
EHRs also have a clear advantage over
purely administrative data sources in
retrospective studies, as they contain
access to discrete, longitudinal
observations (eg, blood pressure
measurements, serial laboratory
tests) that can be used to strengthen
statistical models pertaining to the
outcomes of interest.6
Early experience using EHRs as tools
in CER has shown some promising
results,7 but methodological and
practical challenges must be addressed
to leverage these systems to their full
potential. Current EHRs are designed
for frontline patient care delivery rather
than for research. As such, EHR data
quality is subject to the idiosyncrasies
of daily practice operations (eg, patients
skipping appointments with resultant
long intervals between observations,
variations in provider behavior) and
does not match the quality of data
garnered from clinical trials.
Likewise, treatment decisions in practice
generally are determined by patientand provider- specific factors rather
than randomly, so observational studies
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relying on EHR data need analytic
techniques that account for confounding.
Another major obstacle in use of
EHRs for CER is missing data.
This issue stems largely from the
relative immaturity of these systems
and the recording of information in
inaccessible “free text” fields, rendering
it essentially lost to the researcher
without manual chart review. With
the exception of a few early adopter
health care delivery organizations,
most EHR patient populations have
accrued less than 5 years of data. This
can reduce the available sample size
when retrospectively evaluating the
associations between interventions and
outcomes in chronic diseases because
new user designs (wherein only those
patients with an incident disease
diagnosis captured in the EHR are
eligible for the cohort) are optimal for
these types of studies to minimize bias.8
Finally, the lack of standardization
among vendors has hampered
data-sharing efforts between sites.
With disparate EHRs, a significant
amount of data transformation and
configuration are required for systems
to exchange information.9
Applied solutions to the aforementioned
challenges are actively being pursued
by the CER and medical informatics
communities. With a wide variety
of uses, natural language processing
(NLP) appears to be an extremely
potent tactic to access data trapped in
EHR free text fields, and the Agency
for Healthcare Research and Quality
(AHRQ) currently is funding a grant
to create a common NLP platform
that can interface with EHR data to
conduct CER.10 Statistical methods,
such as propensity scoring and inverse
probability weighting,11,12 have been
(continued on page 10)
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used successfully to help counter
potential confounding in observational
studies using EHR data.
The “Meaningful Use of EHRs”
incentive program and plans for
electronic reporting of Centers for
Medicare and Medicaid Services Core
measures has heightened the emphasis
on standardization of EHR data
element specifications, and data-sharing
consortiums between systems, intended
to support CER, also are developing
independently.13 Pooling data among
multiple sites will resolve sample size
problems and facilitate procuring CER
information on subgroups.
Given that several federal agencies
are sponsoring CER (eg, AHRQ’s
Effective Health Care Program,
National Institutes of Health, and
the recently formed Patient-Centered
Outcomes Research Institute) as well
as the interests of industry in this area,
the pace of innovation surrounding use
of EHRs in CER likely will be brisk.
Even though EHRs are viewed as
a part of larger systemic changes to
drive health care improvements,3
expectations surrounding EHRs in
CER must be pragmatic. EHRs should

be promoted as powerful tools that can
facilitate CER efficiency rather than as
a singular solution. The broad rollout
of EHRs across US health care delivery
organizations affords a window of
opportunity to deploy these systems
in a way that will help reach the vision
of CER as a valuable resource for
informed health care decision making.
Andrew Masica, MD, MSCI, is the
Director of Clinical Effectiveness for the
Baylor Health Care System in Dallas,
TX. He can be reached at andrew.
masica@baylorhealth.edu.
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Key Health Reform Web Sites
Starting in 2010 and continuing through 2014, the Affordable Care Act will
be implemented, increasing access to affordable health care for individuals,
families, seniors, and businesses. The following links to time lines illustrate
implementation of the legislation.
http://www.whitehouse.gov/healthreform/timeline
The implementation time line below from the Kaiser Family Foundation is an
interactive tool designed to explain how and when the provisions of the health
reform law will be implemented over the next several years.
http://healthreform.kff.org/timeline.aspx

Electronic Health Record Incentive Program
The Medicare and Medicaid Electronic Health Record (EHR) Incentive
Programs will provide incentive payments to eligible professionals, eligible
hospitals, and critical access hospitals as they adopt, implement, upgrade, or
demonstrate meaningful use of certified EHR technology.
http://www.cms.gov/ehrincentiveprograms/

Medicare Shared Savings Program
The Medicare Shared Savings Program provides incentives for participating
health care providers who agree to work together and become accountable for
coordinating care for patients. Providers who band together through this model
and who meet certain quality standards based upon, among other measures,
patient outcomes and care coordination among the provider team, may share in
the savings they achieve for the Medicare program. The higher the quality of
care providers deliver, the more shared savings the providers may keep.
https://www.cms.gov/sharedsavingsprogram/05_News.asp
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